Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Endocr Pract. 2013 Jul-Aug;19(4):638–643. doi: 10.4158/EP12288.OR

Figure 2.

Figure 2

Thirty-two percent of respondents never need to refer thyroid cancer patients to another facility. Of those who would refer a 30 year old woman with distant metastases from papillary thyroid cancer and extensive local disease, request for a clinical trial is the most common reported reason for referral, followed by request for high dose radioactive iodine and/or dosimetry.